ClinicalTrials.govpublic full text
Phase II Protocol for CLL With Fludarabine and Cyclophosphamide With Rituximab (FCR) Plus Lenalidomide
chronic lymphocytic leukemia (cll), cll, fcr, rituximab, lenalidomide, cyclophosphamide, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 803778
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.